VNDA CLASS ACTION ALERT: Hagens Berman Alerts Vanda Pharmaceuticals (VNDA) Investors to Securities Class Action and April 26, 2019 Lead Plaintiff Deadline

03/07/2019

San Francisco - Hagens Berman Sobol Shapiro LLP alerts investors in Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) to the April 26, 2019 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Eastern District of New York.  If you purchased or otherwise acquired Vanda securities between November 4, 2015 and February 11, 2019 (the “class period”) and suffered losses contact Hagens Berman Sobol Shapiro LLP.  For more information about the case click

https://www.hbsslaw.com/cases/VNDA

or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing

VNDA@hbsslaw.com.

According to the complaint, during the class period Defendants misled investors about (1) Vanda’s engagement in a fraudulent scheme in which it promoted the off-label use of 2 drugs (Fanapt and Hetlioz), (2) Vanda’s fraudulent receipt of drug reimbursements from the government by abusing Medicare, Medicaid, and Tricare programs, and (3) Vanda’s use of misleading promotional materials for the drugs.

“We’re focused on investors’ losses, matters raised in the recently unsealed whistleblower complaint, and the FDA’s apparent view that the Company used improper promotional materials,” said Hagens Berman partner Reed Kathrein.

Whistleblowers:  Persons with non-public information regarding Vanda should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 510-725-3000 or email VNDA@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 78 attorneys in 9 offices across the country.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes can be found at www.hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Contact:
Reed Kathrein, 510-725-3000


Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.

Back to all cases

Contact:

Please fill out the form below and we will get back to you as soon as we can.
 
*
*
*
*
*
*
*
*
*
*
Upload your trade data *
File Upload *
Please Explain Your Potential Legal Claim *
*
*
 

Case videos

Case Gallery

Case Timeline

03/07/19: Investigation

Related News